Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riqiang Yan

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Translational Neurodegeneration|July 16, 2016
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugsRiqiang Yan
Frontiers in Molecular Neuroscience|May 5, 2017
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2Riqiang Yan
Idrugs : the Investigational Drugs Journal|July 25, 2009
CHI's Eighth Annual World Pharmaceutical Congress. Targeting Alzheimer's with novel therapeutics: Part 2Riqiang Yan
The Lancet. Neurology|February 22, 2014
Targeting the β secretase BACE1 for Alzheimer's disease therapyRiqiang Yan, Robert Vassar
International Journal of Clinical and Experimental Pathology|July 28, 2010
Inhibition of BACE1 for therapeutic use in Alzheimer's diseaseXiaoyang Luo, Riqiang Yan
Translational Neurodegeneration|September 1, 2017
Role of BACE1 in Alzheimer's synaptic functionBrati Das, Riqiang Yan
CNS Drugs|March 5, 2019
A Close Look at BACE1 Inhibitors for Alzheimer's Disease TreatmentBrati Das, Riqiang Yan
Neurobiology of Disease|October 17, 2025
Tubular ER dysfunction in neurodegenerative diseasesMd Golam Sharoar, Riqiang Yan
Molecular Neurodegeneration|November 13, 2020
Activity of Alzheimer's γ-secretase is linked to changes of interferon-induced transmembrane proteins (IFITM) in innate immunityAnnie Y Yao, Riqiang Yan
Reviews in the Neurosciences|November 25, 2016
Effects of altered RTN3 expression on BACE1 activity and Alzheimer's neuritic plaquesMd Golam Sharoar, Riqiang Yan
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Translational Neurodegeneration|July 16, 2016
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugsRiqiang Yan
Frontiers in Molecular Neuroscience|May 5, 2017
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2Riqiang Yan
Idrugs : the Investigational Drugs Journal|July 25, 2009
CHI's Eighth Annual World Pharmaceutical Congress. Targeting Alzheimer's with novel therapeutics: Part 2Riqiang Yan
The Lancet. Neurology|February 22, 2014
Targeting the β secretase BACE1 for Alzheimer's disease therapyRiqiang Yan, Robert Vassar
International Journal of Clinical and Experimental Pathology|July 28, 2010
Inhibition of BACE1 for therapeutic use in Alzheimer's diseaseXiaoyang Luo, Riqiang Yan
Translational Neurodegeneration|September 1, 2017
Role of BACE1 in Alzheimer's synaptic functionBrati Das, Riqiang Yan
CNS Drugs|March 5, 2019
A Close Look at BACE1 Inhibitors for Alzheimer's Disease TreatmentBrati Das, Riqiang Yan
Neurobiology of Disease|October 17, 2025
Tubular ER dysfunction in neurodegenerative diseasesMd Golam Sharoar, Riqiang Yan
Molecular Neurodegeneration|November 13, 2020
Activity of Alzheimer's γ-secretase is linked to changes of interferon-induced transmembrane proteins (IFITM) in innate immunityAnnie Y Yao, Riqiang Yan
Reviews in the Neurosciences|November 25, 2016
Effects of altered RTN3 expression on BACE1 activity and Alzheimer's neuritic plaquesMd Golam Sharoar, Riqiang Yan
Pageof 10